Company / PP&E per Share
Allogene Therapeutics, Inc. PP&E per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.34
FY2025
5-year range
$0.34 / $0.88
FY2021-FY2025
Trend
-32.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has declined for 4 consecutive years, from $0.88 in FY2021 to $0.34 in FY2025.
Based on SEC 10-K filings.
0.34 in FY2025 with a 3-year CAGR of -25.9%.
Declined from $0.69 to $0.34 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -25.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Allogene Therapeutics, Inc.'s pp&e per share has declined for 4 consecutive years.
- In FY2025, pp&e per share decreased 32.7% year-over-year.
- Peak pp&e per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | -32.7% |
| FY2024 | $0.51 | -26.4% |
| FY2023 | $0.69 | -17.8% |
| FY2022 | $0.84 | -3.7% |
| FY2021 | $0.88 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026